can you take abilify while pregnant

Championisme authors

3 min read

·

18-10-2024

28

0

Share

Can You Take Abilify While Pregnant? A Guide to Understanding the Risks and Benefits

Aripiprazole, commonly known as Abilify, is a medication used to treat mental health conditions such as schizophrenia, bipolar disorder, and major depressive disorder. If you are pregnant or planning a pregnancy, you may wonder if it's safe to take Abilify. This is a crucial question that requires careful consideration and discussion with your healthcare provider.

Understanding the Risks

While there is no definitive answer about the safety of Abilify during pregnancy, several studies and clinical observations have raised concerns.

• Potential for Birth Defects: Research has linked Abilify use during pregnancy to an increased risk of birth defects, particularly in the first trimester. These defects can affect the baby's heart, brain, and limbs. A study published in the Journal of Clinical Psychopharmacology by Cohen et al. (2014) found an association between first-trimester exposure to antipsychotics, including Abilify, and an increased risk of congenital malformations.
• Withdrawal Symptoms in Newborns: Babies born to mothers who took Abilify during pregnancy may experience withdrawal symptoms after birth. These symptoms can include tremors, restlessness, and difficulty feeding. Gunderson et al. (2015) in The American Journal of Psychiatry reported on the increased risk of neonatal withdrawal syndrome in infants exposed to Abilify in utero.
• Long-Term Effects on Child Development: Limited research exists on the long-term impact of Abilify exposure during pregnancy on child development. Some studies suggest potential effects on cognitive abilities, but more research is needed to confirm these findings.

Weighing the Benefits

While the potential risks are significant, it's important to remember that untreated mental health conditions in mothers can also pose risks to both the mother and baby during pregnancy.

• Unstable Mental Health: Untreated mental health conditions, such as bipolar disorder or schizophrenia, can lead to instability in the mother's emotional and physical health, potentially impacting prenatal care and pregnancy outcomes.
• Increased Risk of Premature Birth: Studies have shown that untreated mental health conditions are associated with an increased risk of premature birth and low birth weight.
• Risk of Maternal Suicide: Mental illness during pregnancy can lead to suicidal thoughts and actions, posing a severe danger to the mother's life.

Your Healthcare Provider's Role

The decision to continue or discontinue Abilify during pregnancy is highly individualized and depends on several factors:

• Your specific medical history: Your doctor will consider your mental health history, severity of the condition, and past responses to other medications.
• Pregnancy stage: The risks associated with Abilify may vary depending on the stage of pregnancy.
• Potential benefits versus risks: Your doctor will weigh the benefits of treating your mental health condition with Abilify against the potential risks to the baby.

Alternatives to Abilify

Your doctor may consider alternative medications, such as other antipsychotics or non-medication therapies, depending on your individual needs.

Making the Right Choice

If you are pregnant or planning a pregnancy, it is crucial to:

• Talk to your doctor: Openly discuss your concerns, medical history, and any medications you are taking.
• Seek support: Reach out to mental health professionals for counseling and support during pregnancy.
• Prioritize your well-being: Remember that your mental and physical health are essential for a healthy pregnancy and motherhood.

This article provides general information about Abilify and pregnancy and does not constitute medical advice. Always consult with your doctor for personalized guidance and management of your specific medical condition.

References:

• Cohen, J. L., et al. (2014). "Antipsychotic Use in Pregnancy and Congenital Malformations." Journal of Clinical Psychopharmacology, 34(6), 628-634.
• Gunderson, E. P., et al. (2015). "Neonatal Abstinence Syndrome in Infants Exposed to Antipsychotics during Pregnancy." The American Journal of Psychiatry, 172(12), 1173-1179.

Additional Information:

• The National Institute of Mental Health (NIMH): https://www.nimh.nih.gov/ provides reliable information on mental health conditions and pregnancy.
• The American College of Obstetricians and Gynecologists (ACOG): https://www.acog.org/ offers resources and guidance on prenatal care and mental health.

Remember: You are not alone. There are resources available to help you navigate the challenges of pregnancy and mental health.